Uganda Receives First Long-Acting HIV Prevention Injection
The Story
Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year. This marks a significant step in the country’s efforts to curb new infections. An initial shipment of 19,200 doses of the drug arrived in the country this week. This arrival followed the approval of the drug for use by the National Drug Authority (NDA).
Perspective
The provided source article does not contain any direct quotes or attributed perspectives from government officials, health advocates, or other individuals.
Why This Matters
The arrival of the shipment represents a new tool for HIV prevention in Uganda due to its long-acting nature, requiring administration only twice a year. This development is part of the country's ongoing efforts to reduce new HIV infections.
What's Next
The source article does not specify any upcoming events, plans, or timelines related to the distribution or rollout of the drug.